论文部分内容阅读
瑞士伯尔尼消息:斯坦福医学中心正在研究治疗囊性纤维化病人肺部感染的一种新方法。儿科副教授Richard B Moss在一次记者招待会上说:“我们根据抑制炎症反应的原理,可能开始研制出新型疗法.因为目前应用物理方法,将粘液排出肺部并试图抑制微生物繁殖的方法是一种无效的措施. Moss在欧洲囊性纤维化研究小组的一次会议上称,对96例囊性纤维化病人的前瞻性研究结果为这种新方法提供了依据. 他说,有36％患者存在循环免疫复合物,
Berne, Switzerland: Stanford Medical Center is studying a new method of treating lung infections in patients with cystic fibrosis. Pediatrics Associate Professor Richard B Moss said in a press conference: "Based on the principle of inhibiting the inflammatory response, we may start to develop new therapies.Because of the current application of physical methods, mucus is excreted from the lungs and trying to inhibit the propagation of microorganisms is a In a meeting of the European Cystic Fibrosis Syndrom, Moss said the results of a prospective study of 96 patients with cystic fibrosis provided the basis for this new method, saying that 36% of patients had cycles Immune complexes,